000			01805 a2200469 4500
005			20250517010214.0
264		0	_c20150512
008			201505s 0 0 eng d
022			_a1945-7197
024	7		_a10.1210/jc.2014-3594 _2doi
040			_aNLM _beng _cNLM
100	1		_aPalacios, Santiago
245	0	0	_aTreatment satisfaction in postmenopausal women suboptimally adherent to bisphosphonates who transitioned to denosumab compared with risedronate or ibandronate. _h[electronic resource]
260			_bThe Journal of clinical endocrinology and metabolism _cMar 2015
300			_aE487-92 p. _bdigital
500			_aPublication Type: Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
650	0	4	_aAged
650	0	4	_aAntibodies, Monoclonal, Humanized _xtherapeutic use
650	0	4	_aBone Density _xdrug effects
650	0	4	_aBone Density Conservation Agents _xtherapeutic use
650	0	4	_aDenosumab
650	0	4	_aDiphosphonates _xtherapeutic use
650	0	4	_aDrug Substitution
650	0	4	_aEtidronic Acid _xanalogs & derivatives
650	0	4	_aFemale
650	0	4	_aHumans
650	0	4	_aIbandronic Acid
650	0	4	_aMiddle Aged
650	0	4	_aOsteoporosis, Postmenopausal _xdrug therapy
650	0	4	_aPatient Satisfaction
650	0	4	_aRisedronic Acid
650	0	4	_aTreatment Outcome
650	0	4	_aAssessment of Medication Adherence
700	1		_aAgodoa, Irene
700	1		_aBonnick, Sydney
700	1		_aVan den Bergh, Joop P
700	1		_aFerreira, Irene
700	1		_aHo, Pei-Ran
700	1		_aBrown, Jacques P
773	0		_tThe Journal of clinical endocrinology and metabolism _gvol. 100 _gno. 3 _gp. E487-92
856	4	0	_uhttps://doi.org/10.1210/jc.2014-3594 _zAvailable from publisher's website
999			_c24463337 _d24463337